Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian markets close flat
Tue, 28 Jan Closing

The unexpected rate hike announcement from the Reserve Bank of India in its monetary policy review led to a slump in Indian equity markets today. After a day-long volatile trading session, the markets closed on a flat note. Banking stocks stood weaker post the policy review and witnessed maximum selling pressures. That said, the BSE Mid Cap and BSE Small Cap stocks were in favor and the respective indices stood tad higher by 0.01% and 0.14% respectively. The BSE-Sensex closed lower by 24 points and the NSE-Nifty was seen down by 10 points.

On the global front, the Asian indices closed the day on a mixed note and most of the European indices opened the day in green. The rupee was trading at Rs 62.64 to the dollar at the time of writing.

Stocks from the automobile sector closed the day on a mixed note with Maruti Suzuki and Tube Investments leading the pack of losers whereas Escorts and Tata Motors were leading the pack of gainers.

As per leading financial news daily, India's biggest car maker, Maruti Suzuki, announced its earnings performance for the third quarter of FY14. The company reported a whopping 36% rise in profits driven by strong operational performance. On sequential basis, the profits grew 1.6% YoY. Due to Suzuki Powertrain merger, the YoY numbers are not comparable. The company Board has also decided to expand its manufacturing facilities in Gujarat. The board approved for purchase of land in Mehsana district of Gujarat after more than two years. On account of tepid market conditions, the expansion plans were on hold. The expansion plans will be implemented through a 100% Suzuki. Moreover, the Suzuki subsidiary will not sell vehicles manufactured in this plant to anybody else. Rather this subsidiary will produce vehicles as per the Maruti Suzuki requirements and will be sold to the company only.

Stocks from the Indian Pharma sector closed the day on a mixed note with Piramal Enterprises and Lupin Ltd leading the pack of losers and IPCA Labs and Glenmark Pharma leading the pack of gainers.

As per leading financial news daily, IPCA Labs declare its third quarter 2014 earnings today. The company reported 58% YoY growth in net profits and 18.8% YoY growth in total income from operations. According to the company statement, the Income from its domestic formulations business grew 16% to Rs 2.5 bn and exports rose 19% to Rs 5.3 bn YoY. The active pharmaceutical ingredients business in India recorded 12% YoY growth at Rs 419 m and exports of the same grew 16% YoY to Rs 1451 m during 3QFY14. On the operational front, the earnings before interest, tax, depreciation and amortisation jumped 37.3% YoY to Rs 2.17 bn and margin expanded 350 bps to 26.1% in the quarter gone by. IPCA Labs reported forex loss of Rs 24 m during 3QFY14 as against loss of Rs 186 m a year ago. The other income rose from Rs 39.7 m to Rs 54.2 m YoY during 3QFY14.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian markets close flat". Click here!

  

Related Views on News

MARUTI SUZUKI Announces Quarterly Results (3QFY21); Net Profit Up 24.1% (Quarterly Result Update)

Jan 28, 2021 | Updated on Jan 28, 2021

For the quarter ended December 2020, MARUTI SUZUKI has posted a net profit of Rs 19 bn (up 24.1% YoY). Sales on the other hand came in at Rs 222 bn (up 7.4% YoY). Read on for a complete analysis of MARUTI SUZUKI's quarterly results.

MARUTI SUZUKI 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of MARUTI SUZUKI for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of MARUTI SUZUKI. Also includes updates on the valuation of MARUTI SUZUKI.

MARUTI SUZUKI Announces Quarterly Results (1QFY21); Net Profit Down 117.4% (Quarterly Result Update)

Jul 30, 2020 | Updated on Jul 30, 2020

For the quarter ended June 2020, MARUTI SUZUKI has posted a net profit of Rs 2 bn (down 117.4% YoY). Sales on the other hand came in at Rs 41 bn (down 79.2% YoY). Read on for a complete analysis of MARUTI SUZUKI's quarterly results.

What's Behind Tata Motors' Hike in Car and UV Prices? (Views On News)

May 10, 2021

Tata Motors' plan to tackle rise in its raw material prices.

Hero MotoCorp Q4 Net Profit Jumps Over 40% On Strong Operating Performance (Views On News)

May 7, 2021

The company's EBITDA jumped 78.8% YoY on account of cost saving initiatives to offset higher commodity prices and input costs.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


May 14, 2021 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS